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Abstract We examined the effect of N,N,N-trimethylsphingo- apoptosis through regulation of transmembrane signaling (see 
sine (TMS) on the interleukin-l~ (IL-l~)-induced E-selectin ex- [12] for review). Biological functions of sphingoid bases such 
pression in human umbilical vein endothelial cells (HUVEC). as sphingosine, ceramide, sphingosine-l-phosphate, nd N,N- 
Incubation of HUVEC with TMS (0.1-10 ~M) resulted in a 
concentration-dependent i hibition of IL-l~-induced E-selectin dimethylsphingosine (DMS) have been extensively investi- 
expression. Sphingosine or N,N-dimethylsphingosine had no ef- gated, and they have been implicated as important signaling 
fects on the expression. Electrophoretic mobility shift assay re- molecules in regulation of numerous cellular functions [13,14]. 
vealed that TMS inhibited IL-11~-induced NF-IcB activation, N,N,N-Trimethylsphingosine (TMS), a synthetic sphingosine 
which is essential for E-selectin expression. This inhibitory effect derivative, is a potent protein kinase C (PKC) inhibitor [15,16] 
of TMS on IL-l~-dependent endothelial cell activation may and has been shown to inhibit P-selectin expression in human 
partly explain the known anti-inflammatory or anti-metastatic platelets [17], and neutrophil migration [18]. In vivo studies, 
effect of TMS in vivo. TMS significantly suppressed human tumor cell growth in nude 
mice [15] and metastasis of B16 melanoma cell in syngeneic 
Key words: E-selectin; Sphingosine; NF-xB; Interleukin-lfl C57BL mice [19,20]. The molecular mechanism of these sup- 
pression, however, remains to be studied. 
In this study, we examined the effect of TMS on E-selectin 
expression i  HUVEC. E-selectin expression i duced by IL-lfl 
1. Introduction was significantly suppressed by addition of TMS to the culture 
E-Selectin, a member of the selectin family of cell surface media. IL-lfl-dependent NF-xB activation was also inhibited 
lectins is expressed exclusively on endothelial cells stimulated by TMS, suggesting that E-selectin expression is down-regu- 
with interleukin-lfl (IL-lfl), tumor necrosis factor-~ (TNF-~), lated in part through inhibition of NF-xB. 
and bacterial lipopolysaccharide (LPS) [1,2]; its lectin domain 
2. Experimental 
is known to recognize sialosyl Lex(SLe x) [3,4] or its analogs [5] 
particularly under dynamic flow condition [6]. Exposure of 2.1. Materials 
endothelial cells to these stimuli results in rapid transcriptional TMS, DMS and sphingosine were prepared as previously described 
induction of the gene encoding E-selectin, followed by de novo [15,16,21], dissolved and stocked at 2 mM in ethanol/water (50:50 v/v). 
synthesis of E-selectin. Activation of a transcription factor, Bovine serum albumin (BSA), sodium azide, mouse IgG, hydrogen 
peroxide, aprotinin, leupeptin, phenylmethylsulfonyl fluoride (PMSF), 
nuclear factor xB (NF-xB) precedes E-selectin expression in and Nonidet P-40 were purchased from Sigma (St. Louis, MO). Dithio- 
human umbilical vein endothelial cells (HUVEC). NF-xB was threitol (DTT) was from Calbiochem (San Diego, CA). Fetal bovine 
first identified as a protein specific to mature B lymphocytes serum (FBS)was from HyClone (Logan, UT). Recombinant IL-lfl was 
that interacted with the B site of the x light chain gene enhancer purchased from Boehringer Mannheim-Biochemicals (Indianapolis, 
[7]. NF-xB has been implicated in control of transcription of IN). [~,-32p]ATP was from DuPont-New England Nuclear (Wilmington, 
DE ). Anti-E-selectin mouse monoclonal ntibody 3B7 (5 pg mouse 
a number of cellular genes involved in immune and inflamma- IgG per ml culture supernatant) [22] was kindly provided by Otsuka 
tory responses, growth, and adhesion (reviewed in [8]). The Pharmaceutical Co. (Tokyo, Japan). Oligonucleotide probe for the 
activation of NF-xB has been shown to be essential, but not NF-xB consensus sequence (5'-AGTTGAGGGGACTTTCCCA- 
sufficient for E-selectin gene transcription [9]. E-selectin, as well GGC-3') was from Promega (Madison, MI). 
as P-selectin mediate adhesion of blood leukocytes to endothe- 2.2. Cells 
lium, a critical early event in a wide variety of inflammatory HUVEC, their optimized culture medium containing endothelial cell 
processes [1,2]. E-Selectin may also mediate adhesion of cancer growth factor (ECGF), and ECGF were purchased from Cell Systems 
cells to endothelium, leading to cancer spread and metastasis (Kirkland, WA). HUVEC were cultured according to the manufac- 
[5], in the presence of platelets [10]. In the context of anti- turer's instruction and cells between passage three and five were used 
for all experiments. One day prior to experiment, HUVEC were seeded 
adhesion therapy, reagents inhibiting the expression of this on gelatin-coated 96-well flat-bottom plates (Costar, Cambridge, MA) 
adhesion molecule may be good candidates for controlling in- for enzyme-linked immunosorbent assay (ELISA), or on T-25 flasks 
flammation and cancer metastasis [11]. (Corning, Corning, NY) for flow cytometry. 
Sphingolipids have been recognized as playing important 2.3. Treatment of HUVEC 
HUVEC were treated with indicated reagents for 30 min at 37°C, in 
*Corresponding author. RPMI 1640 supplemented with ECGF, 2% L-glutamine and 1% FBS. 
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IL-lfl was then added to the culture medium to a final concentration t-- r 
of 50 IU/ml. Following 4-h incubation with IL- lfl, E-selectin expression ,r- lid 
was measured. 
I II 'I 
ELISA was performed as previously described as slight modification R 
[10]. All manipulations were performed at room temperature and all 
washes were with phosphate-buffered saline (PBS) except as specifically 4- 4- 
Z~ 'r- 'r" v= Z~ ~" v- indicated. Cells were washed twice and fixed with 2% paraformalde- tt 21 21 21 21 
hyde in PBS for 30 min. Following two washes with 20 mM glycine in . . . . .  
PBS, cells were blocked with 2% BSA and 0.1% sodium azide in PBS 
for 1 h. Cells were incubated with 100 ¢tl of 3B7 or with 5/2g/ml mouse '" 
..... , IgG as a control for 1 h. After three washes, anti-mouse IgG antibody j ~ ,~  
conjugated with peroxidase (Southern Biotechnology Assoc., Birming- 
ham, AL) was added and incubated for 1 h. After four washes, soluble 
substrate 1,2-phenylenediamine (Dako, Glostrup, Denmark)in 0.1 M .-e 
citric acid phosphate buffer (pH 5.0), and hydrogen peroxide (final NFlCE~_ e 
concentration 0.03%) were added according to the manufacturer's in-
struction. E-Selectin expression was determined by difference in 
absorbance at wavelength 490 vs. 630 nm. 
2.5. Flow cytometry ;!, 
Flow cytometry was performed as previously described with slight .... * i i 
modification [19]. After incubation with reagents, cells were harvested 
with 0.02% EDTA solution and washed with washing buffer (20 mM 
HEPES, 2% FCS, 0.1% sodium azide in PBS). Following a wash, 3B7 
or mouse IgG was added and incubated for 1 h on ice. Cells were then 
washed four times and incubated with fluorescin-conjugated goat anti- free probe-, 
mouse IgG (TAGO, Burlingham, CA) for 1 h on ice. Cells were washed 
thoroughly and evaluated on EPICS PROFILE (Coulter Corp., Hi- 
aleah, FL). 
2.6. Nuclear extract preparation and electrophoretie mobility shift assay Fig. 1. Concentration-dependent inhibition by TMS of E-selectin ex- 
(EMSA) pression on HUVEC. E-Selectin expression on HUVEC was measured 
Nuclear extracts were prepared from 1 x l0  7 cells using the method by ELISA. HUVEC were treated with TMS for 30 rain. Incubation was 
described by Dignam et al. [23] and Osborn et al. [24] with slight continued in the presence (==) or absence (A) of IL-1 at a final concen- 
modification. Following the incubation, cells were harvested with tration of 50 IU/ml. Cells were treated with IL-1 and sphingosine (Sph) 
0.02% EDTA, washed twice with ice-cold PBS and resuspended in 400 in a similar manner (e). The data represent mean + standard error of 
/21 of buffer A (10 mM HEPES (pH 7.9), 10 mM KC1, 2 mM MgC12, triplicate determinations from three independent experiments. 
0.5 mM DTT, 1 mM PMSF, 5/2g/ml aprotinin and 5/2g/ml leupeptin) 
containing 0.1% Nonidet P-40 for 15 rain on ice, vortexed vigorously 
for 15 s and centrifuged at 14,000 rpm for 30 s. The pelleted nuclei were 
resuspended in 40 ktl of buffer C (20 mM HEPES, pH 7.9, 25% (v/v) 
glycerol, 0.42 M NaC1, 1.5 mM MgC12, 0.2 mM EDTA, 0.5 mM DTT, Maximal effect was observed at 10/2M, where the expression 
0.5 mM PMSF, 5/2g/ml aprotinin and 5/2g/ml eupeptin). After 20 min was approximately 15% of the control value. In these studies, 
on ice, lysates were centrifuged and supernatantscontaining the nuclear TMS was added to the culture medium using ethanol as a 
proteins were transferred to new vials. Protein concentration was deter- vehicle, and the final concentration of ethanol (0.25%) did not 
mined using Bio-Rad protein assay (Bio-Rad, Hercules, CA). 
Oligonucleotide probe for the NF-xB consensus sequence was end- affect cell viability or morphology. Viability under these condi- 
labeled with [y-32p]ATP by incubation with T4 polynucleotide kinase tions (10 ~tM TMS in 0.25% ethanol) was >95% as determined 
(Promega) at 37°C for 10 min. The labeled probe was separated from separately by Trypan-blue exclusion assay. However, when 
unincorporated nucleotides using Quick Spin G-25 column (Boehrin- HUVEC were treated with TMS at concentrations above 20 
ger-Mannheim). /2M, cells became round-shaped, etached from the bottom and 
EMSA was performed as follows. Binding reaction mixtures (20/21) 
containing 10 /2g nuclear protein, 1.5 /2g poly(dI-dC).poly(dI-dC) floated in the medium during the incubation. To confirm that 
(Pharmacia, Piscataway, NJ), 32p-end-labeled NF-xB oligonucleotide the decreased expression of E-selectin was not due to decreased 
probe, 50 mM NaC1, 0.5 mM EDTA, 0.5 mM DTT, 1 mM MgClz,, 5% number of cells by TMS, we also assessed the effect by flow 
(v/v) glycerol and 10 mM Tris-HCl (pH 7.5) were incubated for 20 rain cytometry (Fig. 2). When 5/2M TMS was added, E-selectin 
at 22°C, and electrophoresed through a native 6% polyacrylamide g l 
in a running buffer of 0.5 x TBE, followed by autoradiography, expression was reduced to approximately 25% of control value, 
roughly consistent with the results with ELISA. In contrast, 
neither unsubstituted sphingosine (Figs. 1, 2) nor DMS (data 
3. Results not shown) up to 40 ¢tM produced effects detectable by ELISA 
or flow cytometry. 
3.1. IL-lfl-induced E-selectin expression was inhibited by TMS 
We first examined the effect of TMS on E-selectin expression 3.2. TMS inhibits IL-lfl-induced NF-tcB activation 
in HUVEC by ELISA. Without cytokine stimulation, no E- We next studied the mechanisms by which TMS inhibits the 
selectin expression was detected by ELISA, and TMS itself did E-selectin expression in HUVEC. The signaling pathways lead- 
not induce E-selectin expression. When HUVEC were stimu- ing to E-selectin expression are not fully understood. It is be- 
lated with IL-lf l  (50 IU/ml) for 4 h, they expressed E-selectin, lieved that expression is controlled at the transcriptional level, 
and addition of TMS to cultured medium inhibited E-selectin and is mediated by a transcription factor, NF-KB [8]. We exam- 
expression in a dose-dependent manner as shown in Fig. 1. ined the effect of TMS on NF-~cB activation by EMSA. Incuba- 
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Fig. 2. Confirmation of inhibitory effect of TMS on E-selectin expression by flow cytometry. HUVEC were treated with 5 ktM of sphingosine (panel 
C) or TMS (panel D) for 30 min followed by the 4-h incubation in the presence of IL-1 (50 IU/ml). As control experiments, incubations without 
any treatment (panel A) and with IL-1 only (panel B) were performed in a similar manner. The mean fluorescence intensity of each panel is as follows: 
(A) 5.22, (B) 48.72, (C) 45.15, and (D) 10.14. 
tion of HUVEC with 50 IU/ml IL-lfl resulted in appearance of plex. After 5 h, both complexes were almost eliminated by TMS 
two NF-xB specific DNA-protein complexes, upper and lower treatment. Sphingosine and DMS showed no inhibitory effect 
complexes [25]. TMS (10 /zM) decreased the abundance of at 10 ¢tM (data not shown). These findings suggest that TMS 
NF-lcB binding activity (Fig. 3). When induction of NF-xB down-regulates IL-lfl-induced E-selectin expression in 
binding activity reaches the maximal level after 1 h incubation HUVEC, at least in part through inhibition of NF-xB activa- 
[26], TMS significantly decreased the abundance of lower corn- tion. 
0.35  
A¢OO300.30 " _ ~ ~  
I 
0 0.25 
o~ 
0.20 
C O) 
a 0 .15  
. .~ 
o. 0.10 O 
0.05 
TMS only 
0.00 ~,' i I , i i I 
0.1 0.625 1.25 2.5 5 10 
Sphingolipid Concentration ( p M ) 
Fig. 3. Inhibition by TMS of IL-lfl-induced NF-~B activation. HUVEC were treated with 10,uM TMS for 30 min, then IL-I was added and incubation 
was continued another 1 h (lanes 14)  or 5 h (lanes 5 7). Nuclear extracts were prepared as described in the text and subjected to EMSA. As a 
competition experiment, 50-fold molar excess of unlabeled NF-~cB was added to the binding reaction mixture. NC = negative control without IL-1 
stimulation; comp = unlabeled competitor nucleotide. 
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4. Discussion SLe x oligosaccharides or their analogs in term of anti-inflam- 
matory drug efficiency, because of its metabolic stability and 
We have demonstrated that a synthetic "sphingosine deriva- lower cost of production. 
tive, TMS, down-regulates NF-xB activation and the conse- In summary, we have now demonstrated a further inhibitory 
quent IL-lfl-induced E-selectin expression in HUVEC. Sphin- effects of TMS on NF-xB activation and E-selectin expression 
gosine-related compounds have been extensively studied uring in HUVEC. The present observation provides an additional 
the past 5 years and shown to regulate a wide variety of cellular strong rationale for anti-inflammatory and anti-metastatic ef-
processes, including cellular differentiation, proliferation fects of TMS. 
[13,14], and apoptosis [27]. Among them, ceramide, which is 
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